News About: Goverment
Insurance prices of 1,411 items to be lowed from January 2007
The Ministry of Health and Welfare (MOHW) said on November 17 health insurance prices of 1,411 items will be reduced from January 1st of next year by 17 percent.
According to the MOHW, a total of 5,345 drugs ...
ADHD patient tripled in three years
The number of patients with attention deficit hyperactivity disorder (ADHD) soared over 60.2 percent between 2003 and 2005, because of an increase in the pediatric population and more expanded coverage of national hea...
Production of 20 obsolete drugs to be re-initiated
Influenced by a new positive list system, some drug companies are expected to re-produce a total of 20 obsolete medicines, including Daewoong Pharm's Moxicle tablet and ceftazidime 1g, from December 1.
Their moveme...
Lavish drug distribution expenses to scrutinize by year end.
The government announced to investigate a lavish drug distribution expense until the end of this year mainly for the purpose of advancing the drug distribution environments.
Besides, to boost the discovery of elig...
Next year NHI service price contracts aborted.
The National Health Insurance Corporation (NHIC) and the NHI Payment Council have failed to reach the 2007 NHI service pricing contract by different service providers, which is supposedly proceeded according to Articl...
In-house bioequivalence testing to be acceptable, KFDA says
The government will accept drug maker's in-house bioequivalence testing only, and the acceptable number of the joint bioequivalence testing items will be limited to five, the Korea Food and Drug Administration (KFDA) ...
No progress in pharmaceutical issue
Korea and the United States held talks on drug policy issue surrounding an envisioned bilateral free trade agreement (FTA), but the two sides failed to narrow differences on other issues, ending up only reaffirming th...
22 ingredients added to DMF from Jan.-Feb. 2007
The KFDA said on Nov. 14 that 22 bulk drugs including domperidon had been appointed to report under the DMF schedule, and therefore the industry should submit the DMF (Drug master file) report for these new additi...
No. 11 of Korean new drug for B hepatitis approved.
Bukwang said that as of Nov. 13 the KFDA approved Lebovir 10mg cap (clevudine) for the treatment of chronic B hepatitis, which will become the number 11 of new drug solely developed by a Korean drug company, and...
KFDA to disclose test data
The Korea Food and Drug Administration said it would provide clinical trial data on its website to make sure that patients and scientists and researchers have adequate information.
''This is a major step forward in...
